share_log

康沣生物-B(06922.HK)拟3月27日举行董事会会议批准全年业绩

Kang Feng Bio-B (06922.HK) plans to hold a board meeting on March 27 to approve the annual results

Gelonghui Finance ·  Mar 13 16:54

Gelonghui, March 13 | Kang Feng Bio-B (06922.HK) issued an announcement. The board of directors is pleased to hold a board meeting on March 27, 2024 (Wednesday) to review and approve the Group's annual results and announcements for the year ended 31 December 2023, as well as to consider the payment of a final dividend (if any).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment